Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
219.00
Nov 02 • 8:21 AM ET Dollar change+18.85 Percentage change(9.42%)
Index
RUT
Market Cap
1.50B
Enterprise Value
1.75B
Income
179.92M
Sales
846.72M
Book/sh
57.62
Cash/sh
30.24
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
944
IPO
Apr 24, 2014
P/E
8.66
Forward P/E
8.02
PEG
0.22
P/S
1.77
P/B
3.80
P/C
7.24
P/FCF
5.47
EV/EBITDA
4.55
EV/Sales
2.07
Quick Ratio
4.96
Current Ratio
5.00
Debt/Eq
0.88
LT Debt/Eq
0.83
Option/Short
No / Yes
EPS (ttm)
25.28
EPS next Y
27.32
EPS next Q
5.54
EPS this Y
161.13%
EPS next Y
-0.18%
EPS next 5Y
36.68%
EPS past 3/5Y
- -
Sales past 3/5Y
58.62% 253.48%
EPS Y/Y TTM
155.98%
Sales Y/Y TTM
6.88%
EPS Q/Q
417.67%
Sales Q/Q
-13.62%
Insider Own
32.87%
Insider Trans
-0.01%
Inst Own
43.50%
Inst Trans
1.26%
ROA
19.93%
ROE
57.16%
ROIC
24.87%
Gross Margin
51.26%
Oper. Margin
43.02%
Profit Margin
21.25%
SMA20
6.84%
SMA50
7.40%
SMA200
45.31%
Trades
Shs Outstand
6.84M
Shs Float
4.60M
52W High
226.16 -3.16%
52W Low
83.99 160.75%
Volatility
5.40% 5.39%
ATR (14)
11.40
RSI (14)
58.71
Beta
0.66
Rel Volume
0.15
Avg Volume
154.63K
Volume
1,161
Perf Week
4.78%
Perf Month
1.15%
Perf Quarter
38.78%
Perf Half Y
48.81%
Perf YTD
33.03%
Perf Year
77.96%
Perf 3Y
421.43%
Perf 5Y
-63.50%
Perf 10Y
-95.51%
Prev Close
200.15
Price
219.00
Change %
9.42%
Consensus
Strong Buy
Avg. Price Target
$296.17
Implied Upside
+35.2%
Analysts5incl. previous ratings
Rating Distribution5 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 26, 2026Initiated
LLadenburg Thalmann
Buy$336+53.4%
Sep 04, 2026Resumed
RILY logoRB. Riley Securities
Buy$325+48.4%
Jun 26, 2026Initiated
RILY logoRB. Riley Securities
Buy$290+32.4%
Jun 02, 2026Initiated
LLake Street
Buy$235+7.3%
Nov 12, 2024Reiterated
MMaxim Group
Buy$45 → $50-77.2%
Sep 18, 2024Initiated
MMaxim Group
Buy$45-79.5%
Feb 22, 2023Initiated
NNorthland Capital
Outperform$3-98.6%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saunders Scott JDirectorSep 18 '26Sale214.2520343,493400Sep 18 02:51 PM
Jaumot Frank EDirectorJul 31 '26Option Exercise0.006030753Aug 03 10:10 AM
Grenas Cheryl YvonneDirectorJul 31 '26Option Exercise0.006030670Aug 03 10:07 AM
Saunders Scott JDirectorJul 31 '26Option Exercise0.006030603Aug 03 10:04 AM
Reed Michael LeeDirectorJul 31 '26Option Exercise0.006030670Aug 03 09:59 AM
Hosseinion WarrenPresidentMar 19 '26Buy94.0725223,7067,765Mar 23 01:21 PM
Jaumot Frank EDirectorMar 20 '26Buy93.5615014,033150Mar 23 01:11 PM
Spears KelvinDirectorMar 17 '26Buy94.461094532,137Mar 18 10:40 AM
Montgomery Pamela W.Chief Legal Officer-HealthcareMar 13 '26Buy88.87797,0212,758Mar 16 03:02 PM
Luqman Elisa VChief Legal Officer - SECMar 10 '26Option Exercise0.002,08403,154Mar 11 06:27 PM
Montgomery Pamela W.Chief Legal Officer-HealthcareMar 10 '26Option Exercise0.002,08403,455Mar 11 06:08 PM
Spears KelvinDirectorMar 10 '26Option Exercise0.00183032,209Mar 11 05:52 PM
Chang Michael L.Chief Medical OfficerMar 10 '26Option Exercise0.002,084083,125Mar 11 05:36 PM
Hosseinion WarrenPresidentMar 10 '26Option Exercise0.006,293010,787Mar 11 05:20 PM
Vo Thomas T.Chief Executive OfficerMar 10 '26Option Exercise0.008,33401,846,213Mar 11 05:01 PM
Bates Jon ChristianChief Financial OfficerMar 10 '26Option Exercise0.002,66708,305Mar 11 04:35 PM
Bates Jon ChristianChief Financial OfficerNov 25 '25Buy136.71750102,5325,638Nov 28 02:11 PM
Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.
M.D.Dr. Thomas T. Vo M.B.A.
President & DirectorDr. Warren Hosseinion M.D.
M.B.A.Mr. Jon C. Bates CPA
Chief Operating OfficerMr. Wesley Bamburg FACHE
Chief Medical OfficerDr. Michael Chang M.D.